Skip to main content
Erschienen in: Psychiatric Quarterly 3/2021

15.02.2021 | Original Paper

On-Site Prescription Dispensing Improves Antidepressant Adherence among Uninsured Depressed Patients

verfasst von: Samuel K. Powell, Claire L. Gibson, Ibeawuchi Okoroafor, Josimar Hernandez-Antonio, Elisa M. Nabel, Yasmin S. Meah, Craig L. Katz

Erschienen in: Psychiatric Quarterly | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

The successful treatment of depressive disorders critically depends on adherence to prescribed treatment regimens. Despite increasing rates of antidepressant medication prescription, adherence to the full treatment course remains poor. Rates of antidepressant non-adherence are higher for uninsured patients and members of some marginalized racial and ethnic communities due to factors such as inequities in healthcare and access to insurance. Among patients treated in a free, student-run and faculty-supervised clinic serving uninsured patients in a majority Hispanic community in East Harlem, adherence rates are lower than those observed in patients with private or public New York State health insurance coverage. A prior study of adherence in these patients revealed that difficulty in obtaining medications from an off-site hospital pharmacy was a leading factor that patients cited for non-adherence. To alleviate this barrier to obtaining prescriptions, we tested the effectiveness of on-site, in-clinic medication dispensing for improving antidepressant medication adherence rates among uninsured patients. We found that dispensing medications directly to patients in clinic was associated with increased visits at which patients self-reported proper adherence and increased overall adherence rates. Furthermore, we found evidence that higher rates of antidepressant medication adherence were associated with more favorable treatment outcomes. All patients interviewed reported increased satisfaction with on-site dispensing. Overall, this study provides promising evidence that on-site antidepressant dispensing in a resource-limited setting improves medication adherence rates and leads to more favorable treatment outcomes with enhanced patient satisfaction.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Solomon DA, Keller MB, Leon AC, et al. Multiple Recurrences of Major Depressive Disorder. Am J Psychiatry. 2000;157(2):229–33.CrossRefPubMed Solomon DA, Keller MB, Leon AC, et al. Multiple Recurrences of Major Depressive Disorder. Am J Psychiatry. 2000;157(2):229–33.CrossRefPubMed
3.
Zurück zum Zitat Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime Prevalence and Age-of-Onset Distributions of Dsm-Iv Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.CrossRefPubMed Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime Prevalence and Age-of-Onset Distributions of Dsm-Iv Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.CrossRefPubMed
4.
Zurück zum Zitat Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The Economic Burden of Adults with Major Depressive Disorder in the United States (2005 And 2010). J Clin Psychiatry. 2015;76(2):155–62.CrossRefPubMed Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The Economic Burden of Adults with Major Depressive Disorder in the United States (2005 And 2010). J Clin Psychiatry. 2015;76(2):155–62.CrossRefPubMed
5.
Zurück zum Zitat Cipriani A, Barbui C, Butler R, Hatcher S, Geddes J. Depression in adults: drug and physical treatments. BMJ Clin Evid. 2011;2011:1003.PubMedPubMedCentral Cipriani A, Barbui C, Butler R, Hatcher S, Geddes J. Depression in adults: drug and physical treatments. BMJ Clin Evid. 2011;2011:1003.PubMedPubMedCentral
6.
Zurück zum Zitat Olfson M, Marcus SC. National Patterns in Antidepressant Medication Treatment. Arch Gen Psychiatry. 2009;66(8):848–56.CrossRefPubMed Olfson M, Marcus SC. National Patterns in Antidepressant Medication Treatment. Arch Gen Psychiatry. 2009;66(8):848–56.CrossRefPubMed
7.
Zurück zum Zitat Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The Effects of Adherence to Antidepressant Treatment Guidelines on Relapse and Recurrence of Depression. Arch Gen Psychiatry. 1998;55(12):1128–32.CrossRefPubMed Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The Effects of Adherence to Antidepressant Treatment Guidelines on Relapse and Recurrence of Depression. Arch Gen Psychiatry. 1998;55(12):1128–32.CrossRefPubMed
8.
Zurück zum Zitat Ho SC, Chong HY, Chaiyakunapruk N, Tangiisuran B, Jacob SA. Clinical and Economic Impact of Non-Adherence to Antidepressants in Major Depressive Disorder: A Systematic Review. J Affect Disord. 2016;193:1–10.CrossRefPubMed Ho SC, Chong HY, Chaiyakunapruk N, Tangiisuran B, Jacob SA. Clinical and Economic Impact of Non-Adherence to Antidepressants in Major Depressive Disorder: A Systematic Review. J Affect Disord. 2016;193:1–10.CrossRefPubMed
9.
Zurück zum Zitat Zivin K, Ganoczy D, Pfeiffer PN, Miller EM, Valenstein M. Antidepressant Adherence after Psychiatric Hospitalization among VA Patients With Depression. Adm Policy Ment Health Ment Health Serv Res. 2009;36(6):406–15.CrossRef Zivin K, Ganoczy D, Pfeiffer PN, Miller EM, Valenstein M. Antidepressant Adherence after Psychiatric Hospitalization among VA Patients With Depression. Adm Policy Ment Health Ment Health Serv Res. 2009;36(6):406–15.CrossRef
10.
Zurück zum Zitat Rivero-Santana A, Perestelo-Perez L, Pérez-Ramos J, Serrano-Aguilar P, De las Cuevas C. Sociodemographic and Clinical Predictors of Compliance with Antidepressants for Depressive Disorders: Systematic Review of Observational Studies. Patient Prefer Adherence. 2013;7:151.PubMedPubMedCentral Rivero-Santana A, Perestelo-Perez L, Pérez-Ramos J, Serrano-Aguilar P, De las Cuevas C. Sociodemographic and Clinical Predictors of Compliance with Antidepressants for Depressive Disorders: Systematic Review of Observational Studies. Patient Prefer Adherence. 2013;7:151.PubMedPubMedCentral
11.
Zurück zum Zitat Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of Antidepressant Treatment for Adults With Depression in the United States. Am J Psychiatry. 2006;163(1):101–8.CrossRefPubMed Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of Antidepressant Treatment for Adults With Depression in the United States. Am J Psychiatry. 2006;163(1):101–8.CrossRefPubMed
12.
Zurück zum Zitat Hodgkin D, Volpe-Vartanian J, Alegría M. Discontinuation of Antidepressant Medication among Latinos in the USA. J Behav Health Serv Res. 2007;34(3):329–42.CrossRefPubMedPubMedCentral Hodgkin D, Volpe-Vartanian J, Alegría M. Discontinuation of Antidepressant Medication among Latinos in the USA. J Behav Health Serv Res. 2007;34(3):329–42.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Cuffee YL, Hargraves JL, Rosal M, Briesacher BA, Schoenthaler A, Person S, et al. Reported Racial Discrimination, Trust in Physicians, and Medication Adherence among Inner-City African Americans with Hypertension. Am J Public Health. 2013;103(11):e55–62.CrossRefPubMedPubMedCentral Cuffee YL, Hargraves JL, Rosal M, Briesacher BA, Schoenthaler A, Person S, et al. Reported Racial Discrimination, Trust in Physicians, and Medication Adherence among Inner-City African Americans with Hypertension. Am J Public Health. 2013;103(11):e55–62.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Smith S, Thomas R, Cruz M, Griggs R, Moscato B, Ferrara A. Presence and Characteristics of Student-Run Free Clinics in Medical Schools. JAMA. 2014a;312(22):2407–10.CrossRefPubMed Smith S, Thomas R, Cruz M, Griggs R, Moscato B, Ferrara A. Presence and Characteristics of Student-Run Free Clinics in Medical Schools. JAMA. 2014a;312(22):2407–10.CrossRefPubMed
16.
Zurück zum Zitat Zucker J, Gillen J, Ackrivo J, Schroeder R, Keller S. Hypertension Management in a Student-Run Free Clinic: Meeting National Standards? Acad Med. 2011;86(2):239–45.CrossRefPubMed Zucker J, Gillen J, Ackrivo J, Schroeder R, Keller S. Hypertension Management in a Student-Run Free Clinic: Meeting National Standards? Acad Med. 2011;86(2):239–45.CrossRefPubMed
17.
Zurück zum Zitat Liberman KM, Meah YS, Chow A, Tornheim J, Rolon O, Thomas DC. Quality of Mental Health Care at a Student-Run Clinic: Care for the Uninsured Exceeds that of Publicly and Privately Insured Populations. J Community Health. 2011;36(5):733–40.CrossRefPubMed Liberman KM, Meah YS, Chow A, Tornheim J, Rolon O, Thomas DC. Quality of Mental Health Care at a Student-Run Clinic: Care for the Uninsured Exceeds that of Publicly and Privately Insured Populations. J Community Health. 2011;36(5):733–40.CrossRefPubMed
18.
Zurück zum Zitat Smith SD, Marrone L, Gomez A. Clinical Outcomes of Diabetic Patients at a Student-Run Free Clinic Project. Fam Med. 2014b;46(3):198.PubMedPubMedCentral Smith SD, Marrone L, Gomez A. Clinical Outcomes of Diabetic Patients at a Student-Run Free Clinic Project. Fam Med. 2014b;46(3):198.PubMedPubMedCentral
19.
Zurück zum Zitat Mann CL, Rifkin RA, Nabel EM, Thomas DC, Meah YS, Katz CL. Exploring Antidepressant Adherence at a Student-Run Free Mental Health Clinic. Community Ment Health J. 2019;55(1):57–62.CrossRefPubMed Mann CL, Rifkin RA, Nabel EM, Thomas DC, Meah YS, Katz CL. Exploring Antidepressant Adherence at a Student-Run Free Mental Health Clinic. Community Ment Health J. 2019;55(1):57–62.CrossRefPubMed
20.
Zurück zum Zitat Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, et al. Impact of a Collaborative Care Model on Depression in a Primary Care Setting: A Randomized Controlled Trial. Pharmacotherapy. 2003;23(9):1175–85.CrossRefPubMed Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, et al. Impact of a Collaborative Care Model on Depression in a Primary Care Setting: A Randomized Controlled Trial. Pharmacotherapy. 2003;23(9):1175–85.CrossRefPubMed
21.
Zurück zum Zitat GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 310 Diseases and Injuries, 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–602.CrossRef GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 310 Diseases and Injuries, 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–602.CrossRef
22.
Zurück zum Zitat NYCHealth. Manhattan Community District 11: EAST HARLEM. New York City 2015. NYCHealth. Manhattan Community District 11: EAST HARLEM. New York City 2015.
23.
24.
Zurück zum Zitat Sansone RA, Sansone LA. Antidepressant Adherence: Are Patients Taking Their Medications? Innov Clin Neurosci. 2012;9(5–6):41–6.PubMedPubMedCentral Sansone RA, Sansone LA. Antidepressant Adherence: Are Patients Taking Their Medications? Innov Clin Neurosci. 2012;9(5–6):41–6.PubMedPubMedCentral
25.
Zurück zum Zitat Keller MD, Berndt ER. Depression Treatment: A Lifelong Commitment? Psychopharmacol Bull. 2002;36(Suppl 2):133–41 Review.PubMed Keller MD, Berndt ER. Depression Treatment: A Lifelong Commitment? Psychopharmacol Bull. 2002;36(Suppl 2):133–41 Review.PubMed
26.
Zurück zum Zitat McQuaid EL, Landier W. Cultural Issues in Medication Adherence: Disparities and Directions. J Gen Intern Med. 2018;33(2):200–6.CrossRefPubMed McQuaid EL, Landier W. Cultural Issues in Medication Adherence: Disparities and Directions. J Gen Intern Med. 2018;33(2):200–6.CrossRefPubMed
27.
Zurück zum Zitat Lin EH, Von Korff M, Ludman EJ, et al. Enhancing adherence to prevent depression relapse in primary care. Gen Hosp Psychiatry. 2003;25(5):303–10.CrossRefPubMed Lin EH, Von Korff M, Ludman EJ, et al. Enhancing adherence to prevent depression relapse in primary care. Gen Hosp Psychiatry. 2003;25(5):303–10.CrossRefPubMed
28.
Zurück zum Zitat Liu X, Tepper PG, Able SL. Adherence and Persistence with Duloxetine and Hospital Utilization in Patients with Major Depressive Disorder. Int Clin Psychopharmacol. 2011;26(3):173–80.CrossRefPubMed Liu X, Tepper PG, Able SL. Adherence and Persistence with Duloxetine and Hospital Utilization in Patients with Major Depressive Disorder. Int Clin Psychopharmacol. 2011;26(3):173–80.CrossRefPubMed
29.
Zurück zum Zitat Readdean KC, Heuer AJ, Scott Parror J. Effect of Pharmacist Intervention on Improving Antidepressant Medication Adherence and Depression Symptomology: A Systematic Review and Meta-Analysis. Res Soc Adm Pharm. 2018;14(4):321–31.CrossRef Readdean KC, Heuer AJ, Scott Parror J. Effect of Pharmacist Intervention on Improving Antidepressant Medication Adherence and Depression Symptomology: A Systematic Review and Meta-Analysis. Res Soc Adm Pharm. 2018;14(4):321–31.CrossRef
30.
Zurück zum Zitat Hunot VM, Horne R, Leese MN, Churchill RC. A Cohort Study of Adherence to Antidepressants in Primary Care: The Influence of Antidepressant Concerns and Treatment Preferences. Prim Care Companion J Clin Psychiatry. 2007;9(2):91–9.CrossRefPubMedPubMedCentral Hunot VM, Horne R, Leese MN, Churchill RC. A Cohort Study of Adherence to Antidepressants in Primary Care: The Influence of Antidepressant Concerns and Treatment Preferences. Prim Care Companion J Clin Psychiatry. 2007;9(2):91–9.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Chong WW, Aslani P, Chen TF. Effectiveness of Interventions to Improve Antidepressant Medication Adherence: A Systematic Review. Int J Clin Pract. 2011;65(9):954–75.CrossRefPubMed Chong WW, Aslani P, Chen TF. Effectiveness of Interventions to Improve Antidepressant Medication Adherence: A Systematic Review. Int J Clin Pract. 2011;65(9):954–75.CrossRefPubMed
Metadaten
Titel
On-Site Prescription Dispensing Improves Antidepressant Adherence among Uninsured Depressed Patients
verfasst von
Samuel K. Powell
Claire L. Gibson
Ibeawuchi Okoroafor
Josimar Hernandez-Antonio
Elisa M. Nabel
Yasmin S. Meah
Craig L. Katz
Publikationsdatum
15.02.2021
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 3/2021
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-021-09885-z

Weitere Artikel der Ausgabe 3/2021

Psychiatric Quarterly 3/2021 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.